Kinderpneumologische Praxis Dr. Funck
- Address
- lock Available on a paid plan
Pediatric Respiratory Disease Research
At Kinderpneumologische Praxis Dr. Funck in Neuss, clinical research focuses on Respiratory Tract Diseases in children and adolescents, especially severe eosinophilic asthma and other forms of uncontrolled asthma. The studies are designed to assess whether new treatment options can better reduce flare-ups and improve day-to-day breathing control.
- Evaluating a new therapy for paediatric asthma with a focus on reducing exacerbations
- Studying the role of eosinophilic inflammation in severe asthma
- Assessing treatment effectiveness in children and adolescents with uncontrolled respiratory symptoms
This work supports better management of chronic lung disease in younger patients and helps clarify how emerging respiratory treatments may improve outcomes.
Vaccine Research for Bacterial Infections
The site is also involved in Bacterial Infections and Mycoses research, with studies centered on meningococcal immunization in healthy children, toddlers, and infants. These trials aim to evaluate the safety of vaccine formulations and measure how well they stimulate protective immune responses.
- Testing the safety of a candidate meningococcal vaccine in young age groups
- Measuring immune response after vaccination in children and infants
- Supporting prevention of meningococcal disease through improved immunization strategies
This area of research helps strengthen early-life protection against serious bacterial infections and informs future vaccine development.
Viral Respiratory Infection Studies
Research at this pediatric clinic in Germany also includes Virus Diseases, with a focus on respiratory syncytial virus in infants and toddlers. The clinical trial work is aimed at understanding whether a vaccine can help prevent lower respiratory tract illness and support stronger immune protection in early childhood.
- Preventing RSV lower respiratory tract disease in young children
- Evaluating vaccine effectiveness against a common childhood virus
- Studying immune protection in infants and toddlers
These studies address an important pediatric viral infection and may contribute to better prevention of serious breathing complications in early life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kinderpneumologische Praxis Dr. Funck
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine in Pediatric Populations Compared to Licensed Meningococcal Vaccines | Sanofi Pasteur Inc. | Phase II | Not Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1 | Unknown | 2025-03-10 | 2025-03-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.